Mumbai-based Wellquest CRO, the clinical outsourcing division of India pharmaceutical company Nicholas Piramal, opened a 30,000 square foot research facility in Hyderabad. The 112-bed center boasts separate wards for female and pediatric subjects. The unit will be Wellquest’s second facility in India, which runs a 20,000 square foot center at the Wellspring Hospital in Mumbai. The Mumbai facility consists of a 60-bed ward, six-bed ICU, pharmacy, phlebotomy stations, bioanalytical laboratory and an accredited central pathology laboratory. Wellquest was established in 2000 by Nicholas Piramal and has conducted about 100 pivotal trials and 40 pilot studies. Both facilities are complaint with Good Clinical Practice and Good Laboratory Practice guidelines.